b.danquah
Submits third-party assay reports on material purchased directly. Based in Mysuru.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.11%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042884 | BPC-157 | GGPeps | GGPE-2605-B2560 | PeptideMeter | 2026-Q2 | 98.69 | 3.74 | 101.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042536 | BPC-157 | HJ | HJ-2511-P5900 | Kestrel | 2026-Q2 | 99.33 | 3.27 | 92.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041773 | Enclomiphene citrate | ASY | ASY-{CAT}-1806 | Janoshik | 2025-Q4 | 99.88 | 3.59 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019986 | Tirzepatide | HJ | HJ-2505-H6642 | Janoshik | 2025-Q2 | 99.04 | 5.43 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019346 | Tirzepatide | HYB | HYB-2408-W6301 | Janoshik | 2025-Q1 | 99.01 | 4.38 | 99.3 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004766 | Survodutide | Homopeptide | HOMO-2406-F5091 | Medutest | 2024-Q4 | 99.17 | 4.78 | — | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| HJ | 2 | n<3 |
| GGPeps | 1 | n<3 |
| ASY | 1 | n<3 |
| HYB | 1 | n<3 |
| Homopeptide | 1 | n<3 |